Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Convergent Laser Technologies, operating as Xintec Corporation, is a medical device company based in Alameda, California, specializing in the development and manufacturing of advanced surgical laser systems. Founded in 1984, the company provides a diverse portfolio of laser technologies, including Holmium:YAG, Thulium Fiber, and high-power Diode lasers, primarily for urological, ENT, gynecological, and general surgical applications. Its flagship products, such as the Odyssey 30 and Optica XT, are widely utilized for laser lithotripsy and the treatment of benign prostatic hyperplasia (BPH). Convergent Laser Technologies is recognized for its high-performance, compact, and cost-effective laser solutions and fiber-optic delivery systems, all of which are designed and manufactured in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Convergent Laser Technologies.